How can Syneos Health enhance its Clinical Trial Management System to streamline site activation processes?

Introduction

Enhancing Syneos Health's Clinical Trial Management System (CTMS) to streamline site activation processes is a critical challenge in the clinical research industry. As we explore this improvement opportunity, we'll focus on identifying key pain points, developing innovative solutions, and proposing metrics to measure success. Let's begin by clarifying some crucial aspects of the current system and its context.

Step 1

Clarifying Questions (5 mins)

• Looking at the product context, I'm thinking about the primary users of the CTMS. Could you help me understand who the main stakeholders are in the site activation process, and which group we're primarily focusing on improving the experience for?

Why it matters: Determines the primary user group and their specific needs Expected answer: Clinical Research Associates (CRAs) and Site Coordinators are primary users Impact on approach: Would tailor solutions to address the specific pain points of these user groups

• Considering the current state of the CTMS, I'm curious about its integration capabilities. How well does the system currently integrate with other tools in the clinical trial ecosystem, such as electronic data capture (EDC) systems or regulatory document management platforms?

Why it matters: Identifies potential areas for improvement in data flow and process efficiency Expected answer: Limited integration with some key systems, causing manual data entry and delays Impact on approach: Would focus on enhancing integration capabilities to reduce manual work

• Given the competitive landscape in clinical trial technology, I'm interested in understanding Syneos Health's current market position. How does our CTMS compare to leading competitors in terms of site activation efficiency, and what are the key differentiators?

Why it matters: Helps identify areas where we can leapfrog competitors or shore up weaknesses Expected answer: Middle of the pack in efficiency, with strengths in user interface but weaknesses in automation Impact on approach: Would prioritize automation features while maintaining UI advantages

• Thinking about the broader company objectives, I'm wondering how this CTMS improvement aligns with Syneos Health's overall strategy. What are the key performance indicators (KPIs) that the company is looking to impact through this enhancement?

Why it matters: Ensures alignment between product improvements and company goals Expected answer: Reducing time to site activation by 30% and increasing the number of active trial sites by 20% Impact on approach: Would focus on solutions that directly impact these KPIs